MAPT and Alzheimer disease: Together, these data revealed distinct biochemical and biophysical properties of BDTOs from AD and NDAN individuals, including differences in immunoreactivity, size, and protease resistance, suggesting the presence of structurally distinct tau oligomers among the two groups.